Skip to main content
. Author manuscript; available in PMC: 2014 Oct 28.
Published in final edited form as: Cancer Discov. 2011 Jun 1;1(1):44–53. doi: 10.1158/2159-8274.CD-10-0010

Table 1.

Patient Characteristics

Variable N (%)
Age (mean = 62; range=26-84) <=50 41 (16%)
51~60 73 (29%)
61~70 86 (34%)
>70 55 (22%)

Gender Female 118 (46%)
Male 137 (54%)

Ethnicity Caucasian 209 (82%)
Hispanic 16 (6%)
African American 16 (6%)
Asian 14 (5%)

Smoker Current 23 (9%)
Former 177 (69%)
Never 55 (22%)

Histology Adenocacinoma 160 (63%)
Squamous 46 (18%)
Others 49 (19%)

Prior erlotinib therapy No 139 (55%)
Yes 116 (46%)

ECOG performance status 0 22 (9%)
1 197 (77%)
2 36 (14%)

Prior cytotoxic chemo therapy (median = 2; range=1-6) 1 95 (37%)
2 84 (33%)
3 40 (16%)
4 24 (9%)
5 9 (4%)
6 3 (1%)